3D Global Biotech Inc. (TPEX:6808)

3D Global Biotech Revenue

3D Global Biotech had revenue of 55.30M TWD in the half year ending June 30, 2026, with 26.64% growth. This brings the company's total for the last twelve months to 159.19M, down -51.00% year-over-year. In the year 2025, 3D Global Biotech had annual revenue of 206.74M, down -22.19%. That makes 3D Global Biotech the 40,028th largest company in the world by revenue and 2,071st in Taiwan.

• Revenue (ttm): 159.19M
• Revenue Growth: -51.00%
• P/S Ratio: 15.21
• Revenue / Employee: n/a
• Employees: 43
• Market Cap: 2.42B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 147.39M 71.3%
• United State 59.34M 28.7%

Fiscal year ended Dec 31, 2025 See the full 3D Global Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	206.74M	-58.95M	-22.19%
Dec 31, 2024	265.69M	245.05M	1,187.68%
Dec 31, 2023	20.63M	6.99M	51.24%
Dec 31, 2022	13.64M	2.57M	23.19%
Dec 31, 2021	11.08M	-2.19M	-16.48%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 17, 2026

Data Sources Report a data error